Share Name Share Symbol Market Type Share ISIN Share Description
Quantum Phar. LSE:QP. London Ordinary Share GB00BRTL8Q42 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.25p +0.46% 54.75p 53.50p 56.00p - - - 403,568 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 88.8 -10.9 -16.9 - 92.59

Quantum Phar. Share Discussion Threads

Showing 1401 to 1423 of 1425 messages
Chat Pages: 57  56  55  54  53  52  51  50  49  48  47  46  Older
DateSubjectAuthorDiscuss
27/7/2017
12:26
Interesting local press coverage yesterday: Http://www.thenorthernecho.co.uk/business/15433452.Drugs_firm_Quantum_Pharma_targets_international_growth_in_turnaround_plan/ Extract: "26th July Burnopfield business says partnerships can help it grow industry presence A DRUGS company is pushing ahead with plans to increase its international standing, The Northern Echo can reveal. Quantum Pharma is assessing potential partners to grow around the world.... .....However, Gerard Murray, chief financial officer, told the Echo that the business, which provides work for hundreds of staff, was moving on from its difficulties, with international links on the agenda. He said: “This is a UK-centric business because we develop products with the UK regulator. “The idea would be to look for the right partners in a number of territories where we could introduce products. “We are at the start of that but we have a list and are working to identify partners that could potentially be of benefit. “It would leverage what we have already got and build on what we have developed and what we are developing.” Mr Murray also said the firm’s simplified business model will help its progress. He added: “When you get that, you can identify and manage opportunities and any problems much more quickly.”
rivaldo
09/7/2017
06:47
In all seriousness I would encourage attendance at AGMs. The CEO was kind enough to have a private 20 minute meeting with me afterwards. Thank you
r ball
07/7/2017
12:07
Cheers r, sounds mainly upbeat then.
leontitcombe
06/7/2017
22:03
Quite. But need exec pharma.
r ball
06/7/2017
20:08
Suggest you do not worry about the Non Execs..Plenty of experience in the Pharma Sector.. Non-executives Ian Johnson, Non-Executive Chairman A chartered biologist and a member of the Royal Society of Biology and the Institute of Directors, Ian was appointed Non-executive Chairman in October 2016. Ian is an experienced Director in the healthcare and life science sector. He was founder and Chief Executive Officer of Biotrace International plc until its sale to 3M in 2006 and is currently Executive Chairman of Bioquell PLC. Ian has also served on the boards of various public and private companies in strategic consultancy and business development capacities including Cyprotex plc, Celsis International, Evans Analytical Group, MyCelx Technologies Corporation and AOI Medical Inc. Dr John Brown, Senior Independent Non-Executive Director Dr John Brown was appointed Non-executive Director in October 2016. An experienced Non-executive Director who has extensive experience in the life sciences and healthcare sectors, John is Chairman of Synpromics Ltd and the Cell and Gene Therapy Catapult and a Director of Electrical Geodesics Inc. His board experience includes his roles as Chairman of Kyowa Kirin International, Touch Bionics Ltd, BTG plc, and AxisShield plc, and as a Director of Vectura Group plc.
rosejs2
06/7/2017
18:53
Summary:-Chris and gerrard are stabilising the company.Improved cash positionAre seeking to get uk approvals in the U.K. And Replicating abroadGot a good feeling about execs. Less so about non execs who didn't say much.Concerned over lack of pharma skills on board. Company will probably be bought in 2-3 years time.
r ball
06/7/2017
17:04
Fair play, I need to start attending a few myself. Was it positive? Any highlights?
leontitcombe
06/7/2017
16:47
I was the only one to ask questions. There has to be a point in turning up. I think they were ambit surprised.
r ball
06/7/2017
16:04
Yes. Asked questions. No trading update issued.
r ball
06/7/2017
14:01
Did anyone go to the agm?
leontitcombe
26/6/2017
14:13
Just been tipped: Http://www.aol.co.uk/money/2017/06/26/these-growth-stocks-are-trading-at-major-discounts/ "In fact, here are two stocks which appear to be cheap based on their future prospects. But does that mean they are worth buying today? Impressive update Reporting on Monday was service-led niche pharmaceutical developer, Quantum Pharma(LSE: QP). The company announced the disposal of Total Medication Management Services, which is a homecare dispensary and delivery business which trades as Biodose Services. The disposal is another significant step in the transition of the business as it seeks to focus on its core Specials and Niche Pharmaceuticals divisions. The initial cash consideration on disposal will be £1.75m, with a maximum additional contingent consideration of £0.2m. The sale of the division improves Quantum Pharma's EBITDA (earnings before interest, tax, depreciation and amortisation) margin by eliminating low-margin turnover. In addition, the company's remaining divisions have traded ahead of expectations in the early months of the year. The company expects this to offset the majority of the disposed contribution from Biodose Services in the current year. Looking ahead, Quantum Pharma is expected to report a rise in its bottom line of 31% in the next financial year. Even after today's 3%+ rise in its share price, this leaves the business trading on a price-to-earnings growth (PEG) ratio of just 0.4. This suggests its capital growth potential is high, which means it may be worth buying for the long term."
rivaldo
26/6/2017
13:13
those announcements are very reassuring...... better policies put in place to see us recovering...I feel.
hazl
26/6/2017
08:36
Agreed, very good news all round today. N+1 Singer say this morning: "Going forward we think the recent re-rating of the company, which is moving steadily from turnaround to growth, should continue, assuming further positive underlying momentum at the update scheduled for 9 August."
rivaldo
26/6/2017
08:00
Looks exactly what we wanted. Low margin revenues replaced by growing high margin core business. mgt are executing swiftly on plan. Remaining business can either grow profitably or is now a very attractive bolt on acquisition to another pharma co now that it is cleaned up. Good turnaround story. B
battyliveson
26/6/2017
07:35
Yes, good update. Low margin business sold. Now on track for sustained recovery imo.
aishah
26/6/2017
07:13
Rns looks good re disposal. Also mgt statement that they expect to be ahead of previous estimates
ayl30
14/6/2017
15:53
Soon by the looks of it.
a2584728
12/6/2017
14:56
I think there may be an update on a couple of products coming
a2584728
09/6/2017
16:12
drifting down on no news as weak holders sell out. Will wait for AGM update in just under a month to gauge whether to add, hold or sell (only if nasty surprise). B
battyliveson
30/5/2017
12:32
Great buying opportunity.
a2584728
30/5/2017
10:24
A number of possible reasons for today's drop, Market Makers wanting stock so dropping the price to hit various Stop Loss numbers, short sellers (Not a good idea with the spread between buy and sell nearly 10%) or the final off loading by an Institution who held shares below the notifiable 3% mark... With a recent positive update from the board regarding their turnaround plans and future strategy.. All to play for.
rosejs2
30/5/2017
09:40
well it down a hefty 6pc on no news- is this a buy opp anyone please!
ali47fish
22/5/2017
17:34
Or the sale of the MEDICATION ADHERENCE Division...
rosejs2
Chat Pages: 57  56  55  54  53  52  51  50  49  48  47  46  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20170728 02:53:41